Cape Cod Five Cents Savings Bank purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 26,703 shares of the financial services provider’s stock, valued at approximately $4,954,000.
Several other hedge funds have also recently made changes to their positions in MRSH. Solstein Capital LLC bought a new position in shares of Marsh & McLennan Companies in the 4th quarter worth about $25,000. KERR FINANCIAL PLANNING Corp bought a new position in shares of Marsh & McLennan Companies in the 4th quarter worth about $27,000. City Holding Co. bought a new position in shares of Marsh & McLennan Companies in the 4th quarter worth about $29,000. Headlands Technologies LLC bought a new position in shares of Marsh & McLennan Companies in the 2nd quarter worth about $29,000. Finally, Financial Life Planners bought a new position in shares of Marsh & McLennan Companies in the 3rd quarter worth about $32,000. 87.99% of the stock is owned by institutional investors.
Marsh & McLennan Companies Trading Up 0.3%
NYSE MRSH opened at $168.67 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market capitalization of $81.49 billion, a price-to-earnings ratio of 21.08, a PEG ratio of 2.45 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $220.32.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on MRSH shares. Keefe, Bruyette & Woods raised their target price on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research note on Friday, April 17th. Bank of America dropped their price target on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a research note on Tuesday, April 14th. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target on the stock in a research note on Wednesday, May 6th. Weiss Ratings downgraded Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Finally, Barclays dropped their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $200.19.
Read Our Latest Report on Marsh & McLennan Companies
Insider Buying and Selling at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
